Mobile Menu
Deals & Transactions

Conyers advises Hony Capital Fund V, L.P. and New Good Management Limited on the US$495 million privatization of Simcere Pharmaceutical Group from NYSE

January 2014 Angie ChuDavid Lamb

Conyers advised Hony Capital Fund V, L.P. and New Good Management Limited on the US$495 million privatization of Simcere Pharmaceutical Group from the New York Stock Exchange (“NYSE”) by way of merger. Simcere is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China.

Conyers co-chair David Lamb and Associate Angie Chu, both based in Conyers’ Hong Kong office, acted in this matter. They worked alongside Cleary Gottlieb Steen & Hamilton LLP and Shearman & Sterling LLP.

 


Angie Chu
Associate

Hong Kong   +852 2842 9549
Mobile  +852 6469 3385


David Lamb
Partner

Hong Kong   +852 2842 9511
Mobile  +852 6469 3377


Accolades
_

"Few firms can come close to Conyers on one critical metric, and this is the breadth of the client base."
- IFLR1000